This is a preview of subscription content, log in via an institution to check access.
Reference
Das S, et al. How long is too long: The safe use of maintenance bevacizumab in advanced-stage NSCLC. Lung Cancer Management 4: 163-168, No. 4, Aug 2015 - USA
Rights and permissions
About this article
Cite this article
Bevacizumab. Reactions Weekly 1570, 30 (2015). https://doi.org/10.1007/s40278-015-5602-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-5602-7